Back

Volume 33 , Issue 1
January/February 2013
Pages 43–49

Subepithelial Connective Tissue Graft with Growth Factor for the Treatment of Maxillary Gingival Recession Defect

Robert P. Rubins, DDS, MScD/Paul N. Tolmie, DDS/Kenneth T. Corsig, DMD, MHS/Eric N. Kerr, DDS, MS/David M. Kim, DDS, DMSc

DOI: 10.11607/prd.0000

Gingival recession is a challenging defect for clinicians to treat effectively. A number of recent systematic reviews have identified the connective tissue graft (CTG) in combination with coronally advanced flaps (CAFs) as the most consistently effective treatment for Miller Class I and II defects across all outcome measures. Recent advances in recombinant growth factor technology may provide opportunities for improved outcomes in conjunction with CAF + CTG procedures. In this prospective consecutive case series, recombinant human platelet-derived growth factor BB (rhPDGF-BB) was combined with CTGs for the treatment of Miller Class I or II gingival recession defects. Improved outcomes were seen for keratinized tissue gains and percent root coverage at 6 months postsurgery when compared to historic norms. All other outcome parameters appeared equivalent between the two treatment approaches. The addition of rhPDGF-BB appeared to improve early wound healing as well. (Int J Periodontics Restorative Dent 2013;33:43–49. doi: 10.11607/prd.0000)

Full Text PDF File | Order Article

 

 

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.